Company International Isotopes Inc. OTC Bulletin Board

Equities

US45972C1027

Industrial Machinery & Equipment

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Testing & Measuring Equipment

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Apr. 11	An unknown buyer has entered into an Asset Purchase Agreement to acquire Unused assets in FEP business of International Isotopes Inc for $12.5 million.	CI
Mar. 29	International Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

International Isotopes Inc. manufactures a range of nuclear medicine calibration and reference standards. Its Theranostics Products Segment includes production and distribution of Iodine-131 generic drug products and various isotopically pure radiochemicals. Its Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for teletherapy or irradiation devices, and recycling of expended cobalt sources. Its Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Its Fluorine Products segment is involved in the production of small-scale qualification samples of purity fluoride gas for various industrial applications, and development of laboratory and analytical processes.

USD in Million	2022	Weight	2023	Weight	Delta
Theranostics 55.8 %	6	54.1 %	7	55.8 %	+13.18%
Nuclear Medicine Standards 35.8 %	4	35.6 %	4	35.8 %	+10.27%
Cobalt 8.5 %	1	10.4 %	1	8.5 %	-10.41%

USD in Million	2022	Weight	2023	Weight	Delta
United States 81.7 %	10	86.3 %	10	81.7 %	+3.88%
Non-United States 18.3 %	2	13.7 %	2	18.3 %	+46.35%

Managers	Title	Age	Since
Shahe Bagerdjian CEO	Chief Executive Officer	60	23-05-07
Matthew Cox DFI	Director of Finance/CFO	40	19-03-31
Steve Laflin BRD	Director/Board Member	67	01-05-31
John Miller LAW	General Counsel	60	00-12-31

Members of the board	Title	Age	Since
Christopher Grosso CHM	Chairman	56	02-04-23
Steve Laflin BRD	Director/Board Member	67	01-05-31
Robert Atcher BRD	Director/Board Member	72	17-08-01
Shahe Bagerdjian CEO	Chief Executive Officer	60	23-05-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	520,081,365	141,544,912 ( 27.22 %)	0	27.22 %

Name	Equities	%	Valuation
Kennerman Associates, Inc. 44.68 %	232,233,586	44.68 %	9 M $
John McCormack 19.61 %	101,945,591	19.61 %	4 M $
Christopher Grosso 10.12 %	52,606,673	10.12 %	2 M $
Steve Laflin 2.460 %	12,786,700	2.460 %	511 468 $
Shahe Bagerdjian 1.775 %	9,224,978	1.775 %	368 999 $
Matthew Cox 0.1037 %	538,925	0.1037 %	21 557 $
Capital Square LLC 0.003848 %	20,000	0.003848 %	800 $
Robert Atcher 0.000000 %	0	0.000000 %	- $

Name	Equities	%	Valuation
Kennerman Associates, Inc. 62.43 %	2,630	62.43 %	105 $
John McCormack 16.62 %	700	16.62 %	28 $
Christopher Grosso 11.96 %	504	11.96 %	20 $
Thomas Kershner 1.187 %	50	1.187 %	2 $

International Isotopes, Inc.

4137 Commerce Circle

83401, Idaho Falls

http://www.intisoid.com

Industrials

Industrial Goods

Machinery, Equipment & Components

Industrial Machinery & Equipment

Testing & Measuring Equipment

	1st Jan change	Capi.
SMC CORPORATION	+6.24%	32.19B
MKS INSTRUMENTS, INC.	+13.03%	7.8B
COGNEX CORPORATION	-4.67%	6.84B
BADGER METER, INC.	+19.05%	5.4B
HORIBA, LTD.	+34.45%	3.92B
WUHAN GUIDE INFRARED CO., LTD.	-6.30%	4.03B
RENISHAW PLC	+13.61%	3.69B
INFICON HOLDING AG	+5.47%	3.4B
ESCO TECHNOLOGIES INC.	-10.89%	2.69B

Testing & Measuring Equipment